Innate Pharma executive team to take part in H.C. Wainwright conference
Innate Pharma SA said members of its executive team will participate in a fireside chat and one-on-one investor meetings at the H.C. Wainwright 28th Annual Global Investment Conference.
Regulatory News:Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced that members of its executive team will participate in a fireside chat and one-on-one investor mee…